NAOV - ナノビブロニクス （NanoVibronix Inc.） ナノビブロニクスNAOVのチャート
NAOVの企業情報
| symbol | NAOV |
|---|---|
| 会社名 | NanoVibronix Inc （ナノビブロニクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Industrial Specialties |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ナノビブロニックス（NanoVibronix Inc）は医療器械会社である。同社は、非侵襲的な生体応答激活設備に焦点を当てる。同社の製品は、ローカル毛細管灌流及び組織酸素化を増加させるために、超音波を用いて組織再生及び創傷治癒を促進するパッチベースの治療用超音波装置「WoundShield」、感染した創傷滲出液の汚染のない処理を可能にする機能及び患者の移動性を増強させる機能を備えた小型軽量ポンプ「NanoVibronix NPWT」、疼痛を治療し、標的部位内の軟組織の治癒を誘導するためにローカライズされた超音波の効果を提供することで、痛み、筋肉のけいれんや関節の拘縮を治療するための使い捨てパッチベースの治療超音波技術「PainShield」、尿道カテーテルにおけるバイオフィルムの防止、抗生物質の有効性の増加、尿カテーテルの使用に関連する疼痛及び不快感の減少のために設計された超音波ベースの製品「UroShield」を含む。 ナノビブロニクスは米国の医療装置メ―カ―。創傷治癒と疼痛治療を対象とした非侵食性のパッチ式超音波小型トランスデュ―サ―の開発を手掛ける。主要製品にはWoundShield、PainShield、UroShield、NG Shieldがあり、三叉神経痛やスポ―ツによる損傷、急性及び慢性疼痛を局所的に緩和させて治癒に導く。本社所在地はイスラエル・ネシェル。 NanoVibronix, Inc. is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The Company's primary products include PainShield®, UroShield® and WoundShield®, all of which are portable devices suitable for administration at home without assistance of medical professionals. |
| 本社所在地 | 525 Executive Blvd. Elmsford NY 10523 USA |
| 代表者氏名 | Christopher M. Fashek Christopher M. Fashek |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 914-233-3004 |
| 設立年月日 | 37895 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 12人 |
| url | www.nanovibronix.com |
| nasdaq_url | https://www.nasdaq.com/symbol/naov |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -3.24200 |
| 終値（lastsale） | 4.47 |
| 時価総額（marketcap） | 17692049.91 |
| 時価総額 | 時価総額（百万ドル） 16.62340 |
| 売上高 | 売上高（百万ドル） 0.34400 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 14.11040 |
| 当期純利益 | 当期純利益（百万ドル） -4.85300 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 NanoVibronix Inc revenues increased from $104K to $209K. Net loss applicable to common stockholders decreased 37% to $1.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General and Administrative decrease of 8% to $934K (expense) Research and Development decrease of 9% to $287K (expense). |
NAOVのテクニカル分析
NAOVのニュース
NanoVibronix files for US patent linked to UroShield device 2023/03/21 13:33:44 Seeking Alpha
NanoVibronix (NAOV) filed a provisional patent application with the U.S
NanoVibronix says study shows benefit of UroShield in spinal cord injury patients 2023/03/14 13:44:48 Seeking Alpha
NanoVibronix (NAOV) said an independent study showed that the UroShield device demonstrated a decrease in the number of blockages and infections and increase in catheter satisfaction…
Can NanoVibronix Inc. (NASDAQ: NAOV) Still Be Considered A Loss When It’s Up 20.04% YTD? 2023/02/11 20:00:00 Marketing Sentinel
During the last session, NanoVibronix Inc. (NASDAQ:NAOV)’s traded shares were 3.73 million, with the beta value of the company hitting 0.86. At the end of the trading day, the stock’s price was $6.05, reflecting an intraday gain of 38.13% or $1.67. The 52-week high for the NAOV share is $27.20, that puts it down -349.59 … Can NanoVibronix Inc. (NASDAQ: NAOV) Still Be Considered A Loss When It’s Up 20.04% YTD? Read More »
NanoVibronix falls 11% on 1-for-20 reverse stock split 2023/02/08 17:55:55 Seeking Alpha
NanoVibronix (NAOV) said it plans to effect a reverse stock split at a ratio of 1 post-split share for every 20 pre-split shares.The reverse stock split will become effective at 4:05 p.m
NanoVibronix Announces Reverse Stock Split | MarketScreener 2023/02/08 17:02:02 MarketScreener
Common Stock Will Begin Trading on Split-Adjusted Basis on February 9, 2023 … | February 8, 2023
NanoVibronix files for FDA clearance of ultrasound pain therapy device PainShield MD Plus 2022/05/04 13:06:18 Seeking Alpha
NanoVibronix (NAOV) said it submitted a 510(k) application to the U.S. Food and Drug Administration ((FDA)) seeking clearance of PainShield MD PLUS, an ultrasound pain therapy…
NanoVibronix Announces FDA 510(k) Submission for PainShield MD PLUS 2022/05/04 12:30:00 Wallstreet:Online
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its PainShield MD PLUS, its dual-actuator ultrasound pain therapy device. Brian Murphy, CEO of NanoVibronix, stated,
Infatuating stocks: NanoVibronix, Inc. (NASDAQ:NAOV -3.71%), salesforce.com, inc. (NYSE:CRM -3.22%) 2022/04/15 01:20:05 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Infatuating stocks: NanoVibronix, Inc. (NASDAQ:NAOV -3.71%), salesforce.com, inc. (NYSE:CRM -3.22%) appeared first on Stocks Equity .
Hot Stock to Observe: NanoVibronix, Inc. (NASDAQ:NAOV), Ra Medical Systems, Inc. (AMEX:RMED) 2022/04/09 02:22:25 Stock Equity
NanoVibronix, Inc. (NAOV) with the stream of -12.39% also noticed, India Ra Medical Systems, Inc. (RMED) encountered a rapid change of 3.33% in the last hour of Friday’s trading session. … The post Hot Stock to Observe: NanoVibronix, Inc. (NASDAQ:NAOV), Ra Medical Systems, Inc. (AMEX:RMED) appeared first on Stocks Equity .
NanoVibronix Alert: Why NAOV Stock Is Skyrocketing 133% Today 2020/12/02 15:15:25 InvestorPlace
A NanoVibronix (NAOV) alert for investors is in order Wednesday as the medical device company's stock is skyrocketing higher.
NanoVibronix Expands Offerings with Introduction of PainShield Plus® 2020/10/16 12:30:00 Business Wire
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of multiple areas of pain in tandem. Brian Murphy, CEO of NanoVibronix, stated, “The introduction of PainShield Plus is a natural extension of our hig
NanoVibronix News: Why NAOV Stock Is Skyrocketing 104% Today 2020/09/22 20:02:38 InvestorPlace
NanoVibronix (NAOV) news for Tuesday includes approval from the U.S. Food and Drug Administration sending NAOV stock soaring.
The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study 2020/09/04 11:28:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3) Akouos Inc (NASDAQ: AKUS ) FibroGen Inc (NASDAQ: FGEN )(reacted to an adverse clinical readout for a rival drug to treat chronic kidney disease related anemia) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Sutro Biopharma Inc (NASDAQ: STRO ) ( reacted to announcement concerning presentation of positive data for ovarian cancer drug) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 3) Akebia Therapeutics Inc (NASDAQ: AKBA ) (announced negative safety results for a late-stage study of drug to treat chronic kidney disease-induced anemia) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Genfit SA (NASDAQ: GNFT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Homology Medicines Inc (NASDAQ: FIXX ) Immatics NV (NASDAQ: IMTX ) Interpace Biosciences Inc (NASDAQ: IDXG ) Jaguar Health Inc (NASDAQ: JAGX ) Legend Biotech Corp (NASDAQ: LEGN ) Monopar Therapeutics Inc (NASDAQ: MNPR ) NanoVibronix Inc (NASDAQ: NAOV ) Odonate Therapeutics Inc (NASDAQ: ODT ) RA Medical Systems Inc (NYSE: RMED ) Recro Pharma Inc (NASDAQ: REPH ) Rockwell Medical Inc (NASDAQ: RMTI ) Soliton Inc (NASDAQ: SOLY ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Teligent Inc (NASDAQ: TLGT ) Related Link: Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates Stocks In Focus Lilly Gets FDA Nod For 2 Higher Doses of Its Best-selling Diabetes Drug Eli Lilly And Co (NYSE: LLY ) said the FDA approved two additional doses of its Type 2 diabetes drug Trulicity.
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax 2020/09/03 11:55:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …